November 24, 2009

HOT: GSK Pulls Vaccine Due to Potential for Life-Threatening Allergies

By admin

Gee.  It’s a good thing we waived the right to sue GSK on their untested vaccine.

Here’s a hot story about the brew for Canada that people are in a big hurry to have pumped into their arms:
http://www.google.com/hostednews/ap/article/ALeqM5hv_UnE27MKQefLNmQxLUqQF557NQD9C5TKJG0

Sorry folks.  Have you thought of taking Vitamin D capsules instead?

What a massive cluster f**k this whole thing has become.

Monkeys playing with their own feces could have managed this situation better.

Here’s another article about what’s actually in some of the vaccines.

Here are some notes from the article, which comment on an information leaflet distributed by GSK:

  • Trial results for the H5N1 vaccine (the earlier cousin to the H1N1 vaccine):  the product leaflet mentions a study in which the company injected the vaccine into pregnant rats. It found “an increased incidence of fetal malformations” and “delayed neurobehavioural maturation”
  • The leaflet also mentions a study on ferrets. The animals were given adjuvanted and nonadjuvanted H5N1 vaccines and then exposed to the flu. The ferrets that got the adjuvanted vaccine were protected by the vaccine. But those that got the nonadjuvanted vaccine all died.  [This is a massive concern for pregnant women being advised to get the nonadjuvanted version of the H1N1 vaccine].
  • The leaflet also says four of 253 people studied experienced “severe adverse reactions”. Three of the four were deemed to be unrelated to the vaccine, but one case of hypersensitivity (which can mean anything from an allergic reaction to autoimmune disease) was determined “to be related to vaccination”.  That one serious reaction might not sound like a lot, but it actually translates into a rate of 395 cases per 100,000 people. That’s more than 50 times the rate of hospitalization due to H1N1 itself: 7.3 per 100,000 Canadians.
  • Soldiers who received the vaccine had almost 7.5 times the rate of heart inflammation of nonvaccinated personnel, according to a study by U.S. military medical researchers in 2004 in the American Journal of Epidemiology.
  • One of the best examples involves a controversial ingredient present in the H1N1 vaccine: thimerosal. Thimerosal is a form of mercury used in some vaccines as a preservative. Drug makers agreed to phase it out of most vaccines after the U.S. Food and Drug Administration found in 1999 that mercury levels in children who had gotten multiple shots often exceeded safety levels set by the Environmental Protection Agency (EPA). Nonetheless, thimerosal still remains in many flu vaccines.
  • Controversy has raged for years about whether or not thimerosal is behind soaring childhood autism rates. While that debate continues, a 2008 study in the U.K. journal Toxicological and Environmental Chemistry found that boys who were given a vaccine containing thimerosal were nine times more likely to have developmental problems than unvaccinated boys.
  • Simple math tells us an average Canadian pregnant woman—weighing 80 kilograms at term—gets about 56 percent more than the daily safe level of mercury when given a dose of the nonadjuvanted vaccine. By the EPA’s stricter standards, that same dose is actually triple its daily safe level.
  • What’s more, Shaw notes, those daily safety levels were set for consumption of mercury in food, not for injection directly into the body. Injecting a neurotoxin like mercury has much more impact than eating it, he said.
  • Squalene is another controversial component of the swine-flu vaccine.  Debate has raged for years about whether or not squalene is responsible for Gulf War syndrome.
  • Another component of the H1N1 vaccine adjuvant:  polysorbate 80.  Studies have found it can cause severe allergic reactions and hypersensitivity.

My advice folks:  run, don’t walk, away from the clinics.

Research Credit on both stories:  www.cryptogon.com